Literature DB >> 8403496

Triggering of respiratory burst by phagocytosis in monocytes of patients with systemic lupus erythematosus.

E Gyimesi1, M Kavai, E Kiss, I Csipö, G Szücs, G Szegedi.   

Abstract

The triggering of the respiratory burst by phagocytosis via different receptors in monocytes of patients with systemic lupus erythematosus (SLE) was investigated. The superoxide anion synthesis was assayed by reduction of ferricytochrome C that was inhibited by superoxide dismutase. The mononuclear cell suspensions were triggered by IgG-coated latex, C3 complement fragment-coated and uncoated yeast (Saccharomyces cerevisiae). Superoxide generation induced by phagocytosis via Fc gamma R was decreased in monocytes of patients with SLE. On the other hand, MoAbs against Fc gamma RI, Fc gamma RII and especially CR3 could also induce superoxide anion synthesis. At the same time, superoxide generation induced by anti-CR3 could be inhibited with C3-coated yeast.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403496      PMCID: PMC1534380          DOI: 10.1111/j.1365-2249.1993.tb05991.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Binding and endocytosis of erythrocytes sensitized with rabbit IgG via Fc gamma receptors of human monocytes.

Authors:  M Kávai; E Gyimesi; G Szücs; G Szegedi
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

2.  Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes. Antibody characterization and induction of superoxide production in a monocyte cell line.

Authors:  C L Anderson; P M Guyre; J C Whitin; D H Ryan; R J Looney; M W Fanger
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

Review 3.  Membrane complement receptors specific for bound fragments of C3.

Authors:  G D Ross; M E Medof
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

4.  Reduction of ferricytochrome C may underestimate superoxide production by monocytes.

Authors:  M J Arthur; P Kowalski-Saunders; S Gurney; R Tolcher; F G Bull; R Wright
Journal:  J Immunol Methods       Date:  1987-04-02       Impact factor: 2.303

5.  Mononuclear phagocyte function in SLE. I. Bipartite Fc- and complement-dependent dysfunction.

Authors:  R P Kimberly; N L Meryhew; O A Runquist
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Defective immune complex degradation by monocytes in patients with systemic lupus erythematosus.

Authors:  M Kávai; I Csipö; I Sonkoly; J Csongor; G Y Szegedi
Journal:  Scand J Immunol       Date:  1986-11       Impact factor: 3.487

8.  Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization.

Authors:  J E Salmon; R P Kimberly; A Gibofsky; M Fotino
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

9.  Loss of monocyte membrane receptors in patients with SLE.

Authors:  M Kávai; K Lukács; I Sonkoly; I J Jókay; A Berndt; G Szegedi
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

10.  Antitumor effects of hydrogen peroxide in vivo.

Authors:  C F Nathan; Z A Cohn
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  2 in total

1.  Glucocorticosteroid dependent decrease in the activity of calcineurin in the peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

Authors:  S Sipka; K Szucs; S Szántó; I Kovács; G Lakos; E Kiss; P Antal-Szalmás; G Szegedi; P Gergely
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

2.  Superoxide release in juvenile systemic lupus erythematosus.

Authors:  Roberto Marini; Antonio Condino-Neto; Simone Appenzeller; André M Morcillo; Lilian T L Costallat
Journal:  Rheumatol Int       Date:  2011-04-03       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.